The European Journal of Contraception & Reproductive Health Care
1 ta ish
Jurnal · ISSN 1362-5187
Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: Evidence from Uzbekistan
Sheila Raghavan, Tamar Tsereteli, A. Kamilov +5
MaqolaReproductive Health and ContraceptionThe European Journal of Contraception & Reproductive Health Care20130 iqtibosABI